Company: OXBRW
Filing Date: 2025-04-25
Form Type: S-3
Source: 0001641172-25-006292
Chunk: 24

Company: OXBRIDGE RE HOLDINGS Ltd
Filing Date: 2025-04-25
Form: S-3
Chunk 24
---
 “OXBR”.                                                                                                                           |

The number of our ordinary
shares that will be outstanding immediately after this offering as shown above is based on 7,442,922 shares outstanding as of
February 24, 2025. The number of shares outstanding as of February 24, 2025 as used throughout this prospectus, unless
otherwise indicated, excludes:

| ● | 666,250                                                                            
 ordinary shares issuable upon the exercise of options                              
 outstanding as of February 24, 2025, at a weighted average exercise price of $4.26 
 per share;                                                                         |
| ● | 77,745                                                                             
 ordinary shares issuable upon the vesting of restricted                            
 stock awards with a weighted-average grant date fair value of $4.13 per share; and |
| ● | 869,014                                                                            
 ordinary shares reserved for future issuance under                                 
 our 2014 and 2021 Omnibus Incentive Plans.                                         |
| ● | 1,411,768 ordinary shares issuable upon exercise of the ordinary share             
 warrants in offering completed on February 24, 2025.                               |

| 11 |

<div align='center'>RISK FACTORS</div>

You should consider carefully the risks described below, which update and supplement the risk factors discussed under the section titled “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2024, as may be updated by the Company’s subsequent filings under the Exchange Act, that are incorporated by reference in this prospectus, together with other information in this prospectus, the documents incorporated by reference in this prospectus , and any free writing prospectus that we may authorize for use in connection with this offering before you make a decision to invest in our securities. If any of these risks actually occur, our business, operating results, prospects or financial condition could be harmed. This could cause the trading price of our ordinary shares to decline and you may lose all or part of your investment. The risks below and incorporated by reference in this prospectus are not the only ones we face. Additional risks not currently known to us or that we currently deem immaterial may also affect our business operations. Please also read carefully the section above titled “Cautionary Statement Regarding Forward-Looking Statements.”

Risks Relating to the Offering

If you exercise Warrants, you will experience substantial and immediate dilution.

The exercise price of the Warrants is substantially higher than the net tangible book value per share